Half Year 2021 Polynovo Ltd Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Rachael Harwood - Macquarie Research - Analyst : Firstly, just so that I'm really clear, trauma and burns seem to be urgent in nature rather than elective. So I'm just wondering exactly what the driver of the COVID impact is. Are you finding a lower incidence rate of people presenting to hospitals that are eligible for BTM as a result of these lockdowns? Or is it more around surgeons having little time to evaluate and trial a new product?

Question: Rachael Harwood - Macquarie Research - Analyst : Okay. That makes sense. And then, I guess, just following on from Lyanne's question. You mentioned some new GPOs and other accounts signed. Are you starting to see any sales come through from these accounts yet? And then, I guess, do you expect there to be some pent-up demand that will be pulled through once hospital capacity starts to free up? Or how should we start thinking about this?

Question: Elyse Miriam Shapiro - Bell Potter Securities Limited, Research Division - Analyst : Most of mine have already been asked. But just given the fact that we saw a lot of COVID-related delays on sales and market access and hospital entry and now with your additional hires ramping up the sales efforts, how many sites would you say that you're in the late stage kind of that process with -- that you might expect to be signed on over the course of the next 6 months?

Question: Elyse Miriam Shapiro - Bell Potter Securities Limited, Research Division - Analyst : Would you say that it's an improvement, though, over -- of what we saw the last -- for the last half?